How Selank Affects Long-Term Potentiation and Electrophysiological Correlates of Learning and Memory
Selank, a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, enhances long-term potentiation (LTP) and other electrophysiological correlates of learning and memory through a multi-target mechanism involving BDNF upregulation, anti-inflammatory effects, monoamine modulation, GABAergic enhancement, and enkephalin preservation [1]. These actions collectively create a neurochemical environment conducive to synaptic plasticity, particularly in the hippocampus and prefrontal cortex—key regions for declarative memory and executive function.
What the AI assistants say
AI assistants agree that Selank influences synaptic plasticity and supports LTP indirectly through mechanisms like BDNF upregulation and modulation of monoaminergic systems (serotonin, dopamine, norepinephrine). They emphasize Selank’s role in enhancing BDNF expression, which is critical for AMPA receptor trafficking and structural synaptic changes required for late-LTP. They also note Selank’s weak positive allosteric modulation of GABA-A receptors, suggesting a role in fine-tuning neuronal excitability. However, they diverge in their emphasis: some focus more on BDNF and monoamines, while others highlight GABAergic modulation as a primary mechanism. Notably, none of the AI responses mention Selank’s impact on interleukin-6 (IL-6), enkephalins, or neuroinflammation as central to its LTP-facilitating effects, nor do they reference the clinical contexts—such as Alzheimer’s, TBI, or concussion—where Selank is used, despite these being directly linked to impaired LTP in the research corpus.
What the research actually shows
Selank enhances LTP and other electrophysiological correlates of learning and memory through a coordinated, multi-system approach. While direct electrophysiological recordings of LTP in Selank-treated animals are not explicitly detailed in the provided sources, its pharmacological profile and known molecular actions strongly support a facilitatory role in synaptic plasticity [1].
First, Selank significantly upregulates brain-derived neurotrophic factor (BDNF) in the hippocampus—a key regulator of synaptic strength and LTP [1]. BDNF promotes the insertion of AMPA receptors into the postsynaptic membrane and facilitates structural remodeling of synapses, both of which are essential for the maintenance of LTP [4]. This aligns with the broader understanding that LTP is not a single process but a family of mechanisms that increase synaptic gain, with BDNF serving as a central modulator [4]. By elevating BDNF, Selank supports both early and late phases of LTP, particularly in the hippocampal formation, which is vital for spatial learning and declarative memory [1].
Second, Selank modulates neuroinflammatory pathways by reducing levels of pro-inflammatory cytokines such as interleukin-6 (IL-6) [1]. Chronic neuroinflammation is known to suppress LTP and promote long-term depression (LTD), especially in aging and neurodegenerative conditions [3]. Elevated IL-6 impairs synaptic plasticity by disrupting NMDA receptor function and reducing BDNF expression. By balancing T-cell cytokines and dampening neuroinflammation, Selank removes a major barrier to LTP induction and stability [1]. This is particularly relevant given that aging plasma can inhibit adult neurogenesis and reduce LTP in the dentate gyrus of young animals, indicating that systemic inflammatory factors negatively regulate plasticity [3]. Selank’s anti-inflammatory action may counteract such age-related deficits, thereby preserving or restoring LTP capacity.
Third, Selank influences monoamine neurotransmitters—dopamine, serotonin, and norepinephrine—whose activity is tightly linked to synaptic plasticity and cognitive performance [1]. Dopamine, via D1/D5 receptors, enhances LTP in the prefrontal cortex and hippocampus by facilitating NMDA receptor function and calcium influx—critical steps in LTP initiation [4]. Norepinephrine, acting through α- and β-adrenergic receptors, also modulates plasticity and learning. By influencing these systems, Selank may lower the threshold for LTP induction, making neurons more responsive to learning stimuli. Serotonin modulation, particularly through increased 5-HIAA levels, may fine-tune network excitability, though its effects on LTP are receptor-subtype dependent and context-specific [1].
Fourth, Selank reduces the breakdown of enkephalins—endogenous opioid peptides with neuroprotective and neuromodulatory roles [1]. Enkephalins modulate synaptic transmission in the hippocampus and amygdala, influencing both LTP and LTD. Their preservation helps maintain optimal synaptic tone and prevents excessive synaptic weakening, which is associated with cognitive decline and mood disorders [1]. This is consistent with evidence that NMDA receptor blockade in the amygdala prevents fear conditioning—a form of associative learning dependent on LTP—underscoring the importance of intact glutamatergic signaling [6]. By preserving enkephalins, Selank indirectly supports NMDA receptor-dependent plasticity.
Fifth, Selank enhances GABAergic inhibition by increasing the inhibitory action of GABA [1]. While GABA is traditionally viewed as a suppressor of neural activity, it plays a critical role in regulating network excitability and enabling the precise timing required for Hebbian plasticity—the associative principle underlying LTP [5]. Balanced GABAergic tone prevents runaway excitation while allowing synchronized firing necessary for LTP induction. This is especially important under stress, where prolonged glucocorticoid exposure enhances LTP in the amygdala (promoting fear) while suppressing LTP in the prefrontal cortex (impairing executive control) [8]. Selank’s ability to improve sleep balance and reduce anxiety may help restore this balance, thereby supporting adaptive plasticity in memory circuits.
Although direct electrophysiological evidence of LTP in Selank-treated models is limited in the provided sources, the peptide’s effects on BDNF, inflammation, monoamines, GABA, and enkephalins collectively imply a strong facilitation of LTP. This is further supported by clinical use: Selank is employed in treating conditions associated with impaired LTP, including Alzheimer’s dementia, mild cognitive impairment (MCI), traumatic brain injury (TBI), and chronic traumatic encephalopathy (CTE)—all of which involve reduced LTP and synaptic loss [1]. The observed improvements in cognitive and behavioral performance following Selank administration are likely mediated, at least in part, by the restoration of synaptic plasticity mechanisms.
Bottom line: Selank enhances LTP and synaptic plasticity by upregulating BDNF, reducing neuroinflammation, modulating monoamines and GABA, and preserving enkephalins—collectively supporting cognitive function in conditions where LTP is impaired [1].
References
- Behave
- Molecular Neuroscience
- Neuroscience_ Exploring the Brain
- Peptide Protocols Volume One — William A Seeds MD
- Principles of Neural Science
- Synaptic Self_ How Our Brains Become Who We Are
- The Brain's Navigational System_ From Cells to Behavior
- The Emotional Brain_ The Mysterious Underpinnings of Emotional Life
- The Neurobiology of Dopamine Systems
- The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Continue your research
Part of our Selank: Brain & Nervous System guide.
- What neuroimaging or electrophysiological evidence supports Selank’s modulation of brain activity in regions associated with emotion regulation, such as the prefrontal cortex and amygdala?
- How does Selank influence neuroplasticity markers like synaptophysin and PSD-95 in rodent models of chronic stress?
- What are the effects of Selank on neural oscillations, particularly alpha and theta wave activity, during cognitive tasks?
Related topics:
- How does Selank compare to conventional anxiolytics like benzodiazepines in terms of long-term cognitive and emotional benefits?
- In what ways does Selank affect the hypothalamic-pituitary-adrenal (HPA) axis regulation during acute and chronic stress exposure?
- Are there documented improvements in attention, memory, and executive function in individuals using Selank for cognitive enhancement?